Clinical Trials Browser

Phase 2 × Graft vs Host Disease × Maraviroc × Clear all

NCT02799888 2016-06-15

Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation

Phase 2 Unknown

LymphoidMyeloid

Graft vs Host Disease, Lymphoma, Myelodysplastic Syndromes